Ad is loading...
OGN
Price
$15.03
Change
-$0.28 (-1.83%)
Updated
Nov 15 closing price
88 days until earnings call
SCLX
Price
$0.61
Change
-$0.07 (-10.29%)
Updated
Nov 15 closing price
Ad is loading...

OGN vs SCLX

Header iconOGN vs SCLX Comparison
Open Charts OGN vs SCLXBanner chart's image
Organon & Co
Price$15.03
Change-$0.28 (-1.83%)
Volume$2.83M
CapitalizationN/A
Scilex Holding
Price$0.61
Change-$0.07 (-10.29%)
Volume$4.99M
CapitalizationN/A
OGN vs SCLX Comparison Chart
Loading...
OGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
OGN vs. SCLX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGN is a StrongSell and SCLX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (OGN: $15.03 vs. SCLX: $0.61)
Brand notoriety: OGN and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: OGN: 115% vs. SCLX: 231%
Market capitalization -- OGN: $4.73B vs. SCLX: $165.55M
OGN [@Pharmaceuticals: Major] is valued at $4.73B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $165.55M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGN’s FA Score shows that 2 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • OGN’s FA Score: 2 green, 3 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, OGN is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGN’s TA Score shows that 4 TA indicator(s) are bullish while SCLX’s TA Score has 5 bullish TA indicator(s).

  • OGN’s TA Score: 4 bullish, 5 bearish.
  • SCLX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SCLX is a better buy in the short-term than OGN.

Price Growth

OGN (@Pharmaceuticals: Major) experienced а -4.64% price change this week, while SCLX (@Pharmaceuticals: Major) price change was -30.72% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.55%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was +2.00%.

Reported Earning Dates

OGN is expected to report earnings on Feb 13, 2025.

SCLX is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-4.55% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGN($4.73B) has a higher market cap than SCLX($166M). OGN YTD gains are higher at: 10.726 vs. SCLX (-70.103). OGN has higher annual earnings (EBITDA): 1.44B vs. SCLX (-109.1M). OGN has more cash in the bank: 693M vs. SCLX (3.92M). SCLX has less debt than OGN: SCLX (128M) vs OGN (8.76B). OGN has higher revenues than SCLX: OGN (6.26B) vs SCLX (46.7M).
OGNSCLXOGN / SCLX
Capitalization4.73B166M2,849%
EBITDA1.44B-109.1M-1,316%
Gain YTD10.726-70.103-15%
P/E Ratio4.64N/A-
Revenue6.26B46.7M13,411%
Total Cash693M3.92M17,674%
Total Debt8.76B128M6,844%
TECHNICAL ANALYSIS
Technical Analysis
OGNSCLX
RSI
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
53%
Momentum
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
41%
MACD
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
40%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
67%
Bullish Trend 12 days ago
65%
Declines
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
57%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
20%
View a ticker or compare two or three
Ad is loading...
OGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBIDX9.97N/A
N/A
Sterling Capital Behavioral Intl Eq C
JSECX25.93-0.25
-0.95%
JPMorgan Small Cap Equity C
IJSTX16.15-0.19
-1.16%
VY® JPMorgan Small Cap Core Equity S2
IRGFX22.86-0.39
-1.68%
Delaware Ivy Small Cap Growth R6
PHPSX22.05-0.91
-3.96%
ProFunds Pharmaceuticals UltraSector Svc

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-1.83%
BIIB - OGN
34%
Loosely correlated
-2.97%
AMRN - OGN
27%
Poorly correlated
-3.85%
AMGN - OGN
27%
Poorly correlated
-4.16%
SNY - OGN
26%
Poorly correlated
+0.31%
PFE - OGN
26%
Poorly correlated
-4.69%
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and OGN have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-10.31%
OGN - SCLX
13%
Poorly correlated
-1.83%
AMRN - SCLX
11%
Poorly correlated
-3.85%
GRFS - SCLX
10%
Poorly correlated
-0.84%
BIIB - SCLX
10%
Poorly correlated
-2.97%
RHHVF - SCLX
8%
Poorly correlated
-3.12%
More